Univest
Univest
  • Markets

Infinium Pharmachem (INFINIUM) Share Price rises 10% today to Rs 293.15

  • September 30, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Infinium Pharmachem Share Price
Infinium Pharmachem Ltd. (INFINIUM) share price rose to Rs 293.15 today, up 10% from the previous close. Market cap was Rs 418.41 crore.

Infinium Pharmachem Share Price is trading at Rs 293.15, up 10.00% today, with market capitalisation at Rs 418.41 crore. The move places Infinium Pharmachem Share Price firmly among the notable names in today’s Indian Stock Market, and the latest Univest figures confirm the price event. The price move is confirmed in Univest data; a company-specific reason has not been established. For readers tracking Infinium Pharmachem Share Price Today, the key point is simple: the stock moved materially higher from the previous close, while the market cap remains below the sector median for the same industry. In this Infinium Pharmachem Share Price update, the immediate focus is price action first, then valuation and chemicals sector context. Investors watching Infinium Pharmachem Stock News should next monitor whether the share price rise is accompanied by a change in fundamentals or only a short-term price move.

Table of Contents

Toggle
  • Infinium Pharmachem Share Price Today: Price Action Analysis
  • Infinium Pharmachem Ltd. (INFINIUM) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Infinium Pharmachem
  • About Infinium Pharmachem
  • Frequently Asked Questions
    • Why is Infinium Pharmachem Share Price rising today?
    • What is Infinium Pharmachem Share Price today?
    • How much did Infinium Pharmachem Share Price rise?
    • What is the market capitalisation of Infinium Pharmachem?
    • Is Infinium Pharmachem Share Price expensive on valuation?
    • What do ROE and ROCE show for Infinium Pharmachem Share Price?
    • How does Infinium Pharmachem Share Price compare with peers?
    • What should investors monitor next in Infinium Pharmachem Share Price?
  • Track Infinium Pharmachem Share Price on Univest

Infinium Pharmachem Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 293.15
Previous Close Rs 266.5
Today's Move Rs 26.65 (+10%)
Open Rs 269.5
High Rs 293.15
Low Rs 260
Market Capitalisation Rs 418.41 crore
Market Cap Category Micro Cap

Infinium Pharmachem Ltd. (INFINIUM) rose to Rs 293.15 from the previous close of Rs 266.5, a move of Rs 26.65 or 10%. The stock opened at Rs 269.5, reached a high of Rs 293.15, recorded a low of Rs 260.

Infinium Pharmachem Share Price rose 10.00% and is trading at its day high of Rs 293.15. The stock opened at Rs 269.50, touched a low of Rs 260.00 and moved above the previous close of Rs 266.50 by Rs 26.65. This Infinium Pharmachem Share Price Today action shows a clear intraday advance, with the latest Univest figures placing the stock at the top end of the day’s range as of 30 September 2026 at 3:22:59 PM IST. For anyone following Infinium Pharmachem Share Price Live, the move is straightforward price action: higher than the previous close, higher than the open, and trading at the session high. Infinium Pharmachem Share Price news today is therefore centred on the move itself, not on any verified company-specific trigger. The next layer for Infinium Pharmachem Stock Analysis is whether the fundamentals support the current Infinium Pharmachem Share Price level.

Infinium Pharmachem Ltd. (INFINIUM) Fundamental Analysis

Metric Value
Market Capitalisation Rs 418.41 crore
P/E Ratio 34.18x
P/B Ratio 3.43x
ROE 12.32%
ROCE 13.55%
EPS Rs 7.8
Book Value Per Share Rs 77.68
Dividend Yield 0%

Infinium Pharmachem Ltd. (INFINIUM) fundamental metrics show P/E 34.18x, P/B 3.43x, ROE 12.32%, ROCE 13.55%. These ratios show where the company stands today and are not a call to buy or sell.

Infinium Pharmachem Ltd. has a market capitalisation of Rs 418.41 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.18x, P/B at 3.43x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.32% and ROCE of 13.55%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7.8, book value per share of Rs 77.68, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.53x, median ROE of 7.76%, median ROCE of 10%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Chemicals
Industry Chemicals
Benchmark Scope same industry
Company P/E Ratio 34.18x
Benchmark Median P/E 26.53x
Benchmark Average P/E 50.75x
Benchmark P/E Range 5.3x to 769.23x
Company P/B Ratio 3.43x
Benchmark Median P/B 2.06x
Company ROE 12.32%
Benchmark Median ROE 7.76%
Company ROCE 13.55%
Benchmark Median ROCE 10%
Company Market Capitalisation Rs 418.41 crore
Benchmark Median Market Cap Rs 471.93 crore

Infinium Pharmachem Ltd. (INFINIUM) operates in the Chemicals sector, within the Chemicals industry.

Infinium Pharmachem Ltd. (INFINIUM) has a P/E ratio of 34.18x, which is above the benchmark median of 26.53x, a difference of +28.84%. A P/E difference of this kind is a reference point rather than a recommendation.

Infinium Pharmachem Ltd. (INFINIUM) has a ROE of 12.32%, which is above the benchmark median of 7.76%, a difference of +58.76%. Infinium Pharmachem Ltd. (INFINIUM) has a ROCE of 13.55%, which is above the benchmark median of 10%, a difference of +35.5%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Solar Industries India Ltd. SOLARINDS 1,73,740.91 87.56 25.14 32.49 38.16
Pidilite Industries Ltd. PIDILITIND 1,52,683.81 56.52 12.95 24.29 32.38
SRF Ltd. SRF 73,809.78 33.39 4.89 13.8 14.21
Gujarat Fluorochemicals Ltd. FLUOROCHEM 48,773.95 78.87 6.04 7.65 9.58
Navin Fluorine International Ltd. NAVINFLUOR 43,270.44 53.5 10.06 20.24 21.39

Infinium Pharmachem Ltd. (INFINIUM) has a P/E ratio of 34.18x compared with the displayed peer median of 56.52x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.32% compares with a peer median of 20.24% across the companies shown in the table. ROCE stood at 13.55% versus the displayed peer median of 21.39%, providing a capital-efficiency comparison. Infinium Pharmachem Ltd. (INFINIUM) has a market capitalisation of Rs 418.41 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Infinium Pharmachem

  • Infinium Pharmachem Share Price rose 10.00% and is trading at the day high, which makes the intraday move the first point of attention.
  • Infinium Pharmachem Share Price Today sits at Rs 293.15 versus a previous close of Rs 266.50, a clear price rise in early afternoon trade.
  • Infinium Pharmachem Fundamental Analysis shows P/E of 34.18, P/B of 3.43, ROE of 12.32% and ROCE of 13.55%.
  • Infinium Pharmachem Share Price can be read against the Chemicals sector benchmark, where its ROE and ROCE are above the industry median.
  • Infinium Pharmachem Stock News remains focused on verified price action because no company-specific catalyst is established.

About Infinium Pharmachem

Infinium Pharmachem Ltd. operates in the Chemicals sector and Chemicals industry. Infinium Pharmachem Share Price matters to investors because the company sits within a broad industry comparison set, and the latest Univest figures place its market capitalisation at Rs 418.41 crore. The business description available to this article is limited to its sector and industry identity, so the analysis stays anchored to the verified financial profile. In that profile, Infinium Pharmachem Share Price reflects a company with an EPS of Rs 7.80, book value of Rs 77.68 and dividend yield of 0.00%. Those numbers give a basic view of earnings per share, accounting value per share and historical payout profile. For readers tracking Infinium Pharmachem Company News, this combination of market value and valuation ratios is the most concrete way to frame the stock without speculating beyond the data.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Infinium Pharmachem Share Price rising today?

Ans. Infinium Pharmachem Share Price is rising today because the stock is trading 10.00% higher at Rs 293.15. The price move is confirmed in Univest data; a company-specific reason has not been established.

What is Infinium Pharmachem Share Price today?

Ans. Infinium Pharmachem Share Price today is Rs 293.15. It is trading above the previous close of Rs 266.50 and has touched the day high, making the intraday move easy to track.

How much did Infinium Pharmachem Share Price rise?

Ans. Infinium Pharmachem Share Price rose by Rs 26.65, or 10.00%, from the previous close. The move also took the stock above its opening price of Rs 269.50 during today’s trade.

What is the market capitalisation of Infinium Pharmachem?

Ans. Infinium Pharmachem Share Price corresponds to a market capitalisation of Rs 418.41 crore. That places the company below the benchmark median market cap in the same Chemicals industry comparison set.

Is Infinium Pharmachem Share Price expensive on valuation?

Ans. Infinium Pharmachem Share Price trades at a P/E of 34.18 and P/B of 3.43. Versus the same industry median P/E of 26.53, the earnings multiple looks higher on the benchmark.

What do ROE and ROCE show for Infinium Pharmachem Share Price?

Ans. Infinium Pharmachem Share Price comes with ROE of 12.32% and ROCE of 13.55%. Both are above the same industry median, which helps place the stock’s operating return profile in context.

How does Infinium Pharmachem Share Price compare with peers?

Ans. Infinium Pharmachem Share Price trades below Pidilite and Navin Fluorine on valuation multiples, while its ROE and ROCE are above Deepak Nitrite and close to SRF. Market cap is also much smaller than these peers.

What should investors monitor next in Infinium Pharmachem Share Price?

Ans. Investors tracking Infinium Pharmachem Share Price should watch whether the price remains near today’s high and whether future company updates change the fundamental backdrop. Univest data currently confirms the price move, not the cause.

Track Infinium Pharmachem Share Price on Univest

Use Infinium Pharmachem Ltd. (INFINIUM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Infinium Pharmachem Share Price on Univest for live price updates, valuation ratios, market capitalisation, 52-week levels and company context. Univest also helps readers follow Infinium Pharmachem Stock Analysis alongside broader Chemicals sector comparisons and market update context. If you are monitoring Infinium Pharmachem Latest News, Univest keeps the price view and fundamentals in one place.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply